News

Although infections caused by methicillin-resistant Staphylococcus aureus (MRSA) are a prominent concern for cataract surgeons, leading ophthalmologists discuss the pros and cons of performing universal MRSA screening to guide targeted prophylaxis.

Like you, I chose to attend medical school with the goal of helping patients who were ill and needed curing, comforting, or both. So perhaps the financial rewards of a career in medicine have made you feel slightly embarrassed and concerned that people might be resentful or jealous. Well, here’s good news: research suggests we physicians aren't so financially successful after all.

Social media is a highly effective tool for promoting practices’ campaigns, but knowing several key strategies will increase success from advertising.

The combination of camera and recorder products is designed to capture and record ophthalmic procedures for an enhanced surgical workflow.

rarely recognized. Ronald L. Fellman, MD, describes its diagnostic features and management considerations.

The effect of astigmatism varies with different factors and can affect patient satisfaction with multifocal or monofocal IOLs.

Refractive surgery screening devices do not provide results that are interchangeable.

A scleral spacing procedure for the treatment of presbyopia restored near vision in presbyopic emmetropic patients without adverse effects.

Multifocal bi-aspheric ablation profile, micromonovision approach delivers good outcomes

A hydrogel sealant demonstrated significant superiority to suturing for sealing incisions that were leaking when tested immediately after small-incision phacoemulsification and toric IOL implantation.

Boris Malyugin, MD, PhD, explains how he uses a step-wise approach to manage small pupils, starting with an intracameral injection of phenylephrine or epinephrine and eventually working up to pupil expanders.

If explantation of a miniature stainless steel glaucoma shunt becomes indicated, an ab interno technique offers several advantages compared with the traditional external approach.

Dexamethasone intravitreal implant 0.7 and 0.35 mg provided statistically and clinically significant improvement in best-corrected visual acuity and reduction in central subfield retinal thickness with an average of 4 to 5 injections over 3 years.

Technologies will provide better understanding of IOP and patient adherence to topical medications and allow timely adjustments in therapy while reducing the number of office visits.

The 2014 meeting of the American Academy of Ophthalmology will convene in Chicago from Oct. 17 to 21. Visit www.aao.org for the latest updates or to register.

Use of metformin, a drug therapy for the treatment of diabetes, was found to be associated with reduced risk of adult-onset, open-angle glaucoma in a recent study.

The FDA has approved Alimera Sciences’ fluocinolone acetonide intravitreal implant (Iluvien) for the treatment of diabetic macular edema (DME) in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in IOP.

Novaliq GmbH has reported positive phase I results with its clear cyclosporin solution eye drop formulation (CyclASol) in clinical development for patients with dry eye syndrome.

The FDA has approved Allergan’s dexamethasone intravitreal implant 0.7 mg (Ozurdex), a sustained-release biodegradable steroid implant, for the treatment of diabetic macular edema (DME).

Bausch + Lomb’s next-generation sub-micron gel formulation of loteprednol etabonate has been found to be statistically superior to placebo (vehicle gel) in eliminating inflammation and pain following cataract surgery by study day 8-the primary endpoints in the first phase III, multicenter, double-masked, vehicle-controlled, parallel-group study.

Valeant Pharmaceuticals International’s wholly owned subsidiary, Bausch + Lomb, and Nicox S.A. have announced positive top-line results from the pivotal phase III studies conducted with latanoprostene bunod (Vesneo, previously known as BOL-303259-X and NCX 116) for the reduction of IOP in patients with glaucoma or ocular hypertension.

A femtosecond laser can create circular, well-centered capsulotomies to facilitate implantation of capsular tension rings and IOLs without decentration in pediatric patients with Marfan’s syndrome. Tim Schultz, MD, and H. Burkhard Dick, MD, of the University Eye Clinic Bochum, Bochum, Germany, described the case of a 10-year-old boy with Marfan’s syndrome.

The American Medical Association (AMA)-in responding to physicians’ demands for solutions to electronic health record (EHR) systems that have neglected usability as a necessary feature-has outlined eight priorities for improving EHR usability that would benefit caregivers and patients.

The recent agreement between Valeant and Croma-which would provide for the distribution of Croma’s ophthalmology products in Western Europe-is expected to expand Bausch + Lomb’s (B + L) ophthalmic portfolio in the United States.

Nicox S.A has agreed to acquire the Carragelose anti-viral eye drop program from Marinomed Biotechnologie GmbH of Austria. The acquisition will provide Nicox with an anti-viral ophthalmic product, expected to launch in Europe within 2 years and pending CE marking.

Ophthalmology technology from Quantel Medical and AcuFocus recently received CE Mark approval.

Alphaeon Corp. has entered into a definitive agreement to acquire all of the outstanding shares and assets of Clarion Medical for an undisclosed sum.

The European Society of Cataract and Refractive Surgeons (ESCRS) never fails to entice ophthalmology with cutting-edge technology, and the XXXII Congress in London has not disappointed attendees. This year’s congress has displayed a wide range of new technologies from cataract and refractive platforms to diagnostic units to surgical instruments. From all the equipment presented, IOL advances have again captured the attention of attendees.

Valeant Pharmaceuticals International recently hosted a ribbon-cutting ceremony for the new Bausch + Lomb ULTRA contact lens manufacturing lines and solar array assembly at the company's Optics Center in Rochester, NY.

Glaucoma specialists discuss the use of laser peripheral iridotomy and lens extraction as surgical intervention for chronic angle closure.